Fam-trastuzumab deruxtecan-nxki Injection
Fam-trastuzumab deruxtecan-nxki injection may cause serious or life-threatening lung damage, including interstitial lung disease (a condition in which there is scarring of the lungs) or pneumonitis (swelling of lung tissue). Tell your doctor if you have lung disease or breathing problems. If you experience any of the following symptoms, call your doctor immediately: new or worsening cough, difficulty breathing, wheezing, chest tightness, fever, or shortness of breath.
Tell your doctor if you are pregnant, plan to become pregnant, or if you plan to father a child. You or your partner should not become pregnant while you are receiving fam-trastuzumab deruxtecan-nxki injection. If you are able to become pregnant, your doctor may perform a pregnancy test to be sure that you are not pregnant before you receive fam-trastuzumab deruxtecan-nxki injection. If you are female, you should use birth control during your treatment and for 7 months after your final dose. If you are male, you and your female partner should use birth control during your treatment and for 4 months after your final dose. Talk to your doctor about birth control methods that will work for you. If you or your partner becomes pregnant while receiving fam-trastuzumab deruxtecan-nxki injection, call your doctor. Fam-trastuzumab deruxtecan-nxki may harm the fetus.
Keep all appointments with your doctor and the laboratory. Your doctor will order certain tests before and during treatment to check your body’s response to fam-trastuzumab deruxtecan-nxki.
Your doctor or pharmacist will give you the manufacturer’s patient information sheet (Medication Guide) when you begin treatment with fam-trastuzumab deruxtecan-nxki. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer’s website to obtain the Medication Guide.
Talk to your doctor about the risk(s) of receiving fam-trastuzumab deruxtecan-nxki.
🔔 Why is this medication prescribed?
Fam-trastuzumab deruxtecan-nxki injection is used to treat a certain type of breast cancer that cannot be removed by surgery, that has spread to other parts of the body, or has come back after another breast cancer treatment. It is also used to treat certain types of gastric cancer (cancer of the stomach) in adults that has spread to nearby tissues or to other parts of the body after receiving another treatment. Fam-trastuzumab deruxtecan-nxki injection is also used to treat a certain type of non-small cell lung cancer (NSCLC) in adults that cannot be removed by surgery or that has spread to other parts of the body after receiving another treatment. Fam-trastuzumab deruxtecan-nxki is in a class of medications called antibody-drug conjugates. It works by killing cancer cells.
Just under half – 49% – of Americans get their health insurance through their employer, according to the Henry J. Kaiser Family Foundation. Another 19% of Americans are insured under Medicaid, 14% under Medicare, seven% under non-group plans and two% under other public insurers, while nine% of U.S. citizens remain uninsured.
🔔 How should this medicine be used?
Fam-trastuzumab deruxtecan-nxki comes as a powder to be mixed with liquid and injected intravenously (into a vein) over 30 or 90 minutes by a doctor or nurse in a hospital or medical facility. It is usually injected once every 3 weeks for as long as your doctor recommends that you receive treatment.
Your doctor may delay or stop your treatment with fam-trastuzumab deruxtecan-nxki injection, or treat you with additional medications, depending on your response to the medication and any side effects that you experience. Talk to your doctor about how you are feeling during your treatment.
Fam-trastuzumab deruxtecan-nxki injection may cause nausea and vomiting during and after treatment with the medication. Your doctor may give you another medication to help prevent nausea and vomiting.
